Venrock Healthcare Capital Partners III, L.P.

Holdings History for 4D Molecular Therapeutics, Inc. - Common Stock, par value $0.0001 per share (FDMT)

Symbol: FDMT on Nasdaq
Investment type: Equity / Common Stock, par value $0.0001 per share
Latest Disclosed Shares Owned: 677,600 shares
Security Ownership %: 1.5%

Venrock Healthcare Capital Partners III, L.P. ownership in 4D Molecular Therapeutics, Inc. Common Stock, par value $0.0001 per share (FDMT)

15 May 2025 - Venrock Healthcare Capital Partners III, L.P. has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 677,600 shares of 4D Molecular Therapeutics, Inc. Common Stock, par value $0.0001 per share (FDMT). This represents 1.5% ownership of the company. In their previous filing dated 14 Feb 2025, Venrock Healthcare Capital Partners III, L.P. had reported owning 2,952,371 shares, indicating a decrease of +77%. .

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filing time
Venrock Healthcare Capital Partners III, L.P.	1.5%	-82%	$2,202,200	677,600	-2,274,771	-77%	$3.25	13G/A	31 Mar 2025	15 May 2025, 17:44
Venrock Healthcare Capital Partners III, L.P.	6.4%		$9,595,206	2,952,371			$3.25	13G/A	31 Dec 2024	14 Feb 2025, 18:09